Recent studies have described several biomarkers such as lymphopenia, thrombocytopenia, C-reactive protein (CRP), lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), d-dimer, ferritin, and troponin associated with worse clinical outcomes and mortality in COVID-19 (14–20). This evidence concerns the gene GPT and lymphopenia.